Lung function | Association |
---|
β (95%CI) | Mediation (%)a |
---|
FEV1 |
 PA-Moderate |
  Total | 0.085 (0.049, 0.121) |  |
  Direct | 0.077 (0.041, 0.113) |  |
  Indirect via CRP | 0.009 (−0.001, 0.017) | 10.05 |
 PA-High |
  Total | 0.149 (0.106, 0.193) |  |
  Direct | 0.130 (0.086, 0.174) |  |
  Indirect via CRP | 0.019 (0.010, 0.029) | 12.99b |
FVC |
 PA-Moderate |
  Total | 0.131 (0.086, 0.176) |  |
  Direct | 0.123(0.078, 0.168) |  |
  Indirect via CRP | 0.009 (−0.001, 0.017) | 6.58 |
 PA-High |
  Total | 0.207 (0.153, 0.262) |  |
  Direct | 0.188 (0.133,0.243) |  |
  Indirect via CRP | 0.020 (0.010, 0.029) | 9.42b |
- CRP C-reactive protein, CI Confidence interval, FEV1 Forced expiratory volume in one second, FVC Forced vital capacity, PA Physical activity; β: regression coefficient
- Models were adjusted for age, sex, education level, cigarette smoking, alcohol drinking, body mass index, cardiovascular diseases (angina, congestive heart failure and stroke), chronic lung diseases, cancer and dementia
- Total effect is the effect of PA on lung function without CRP; direct effect is the effect of PA on lung function when controlling for CRP; indirect effect is the effect of PA on lung function via CRP
- aMediation (%) is calculated by indirect effect/total effect ×100
- bP<0.001